Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs. chemoimmunotherapy

被引：0
|
作者：
Wang, Ruibin
Ding, Zhijie
Lu, Xiaoxiao
Mavani, Heena
He, Jinghua
Qureshi, Zaina P.
Pinilla-Ibarz, Javier
机构：
[1] Janssen Sci Affairs, LLC, Titusville, NJ USA
[2] Janssen Sci Affairs, LLC, Horsham, PA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19509
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Salkar, Monika
    Saifan, Chadi
    Agatep, Barnabie C.
    Jones, Barton
    Ryan, Olga
    Bacchus, Shaffee
    Stephens, Deborah M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Real-world time to discontinuation of first-line venetoclax plus obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1227 - 1235
  • [23] Real-world time to discontinuation of first-line venetoclax plus binutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2023,
  • [24] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma
    Jacobs, Ryan W.
    Teschemaker, Anna
    Hakre, Shweta
    Tian, Hongping
    Pyrih, Nick
    Wahlstrom, Svea K.
    Cui, Lianzhou
    [J]. BLOOD, 2023, 142
  • [25] Real-World Outcomes for 205 Danish Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
    Aarup, Kathrine
    Enggaard, Lisbeth
    Pedersen, Robert Schou
    Thomsen, Rasmus Heje
    Bergmann, Olav Jonas
    Frederiksen, Mikael
    Christiansen, Ilse
    Nielsen, Tine
    Frederiksen, Henrik
    Niemann, Carsten Utoft
    Andersen, Michael Asger
    [J]. BLOOD, 2019, 134
  • [26] Real-World Outcome of Treatment with Single-Agent Ibrutinib in Patients with Chronic Lymphocytic Leukemia: Results from the Italian Study Evidence
    Molica, Stefano
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Guarini, Attilio
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Innocenti, Idanna
    Massaia, Massimo
    Coscia, Marta
    Pennese, Elsa
    Patti, Caterina
    Reda, Gianluigi
    Tafuri, Agostino
    Regazzoni, Giulia
    Di Candia, Michele
    Mauro, Francesca Romana
    [J]. BLOOD, 2022, 140 : 4178 - 4180
  • [27] Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
    Mauro, Francesca Romana
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Minoia, Carla
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Laurenti, Luca
    Massaia, Massimo
    Cassin, Ramona
    Coscia, Marta
    Patti, Caterina
    Pennese, Elsa
    Tafuri, Agostino
    Chiarenza, Annalisa
    Galieni, Piero
    Perbellini, Omar
    Selleri, Carmine
    Califano, Catello
    Ferrara, Felicetto
    Cuneo, Antonio
    Murineddu, Marco
    Palumbo, Gaetano
    Scortechini, Ilaria
    Tedeschi, Alessandra
    Trentin, Livio
    Varettoni, Marzia
    Pane, Fabrizio
    Liberati, Anna Marina
    Merli, Francesco
    Morello, Lucia
    Musuraca, Gerardo
    Tani, Monica
    Ibatici, Adalberto
    Regazzoni, Giulia
    Di Candia, Michele
    Palma, Maria
    Arienti, Danilo
    Molica, Stefano
    [J]. CANCERS, 2024, 16 (06)
  • [28] Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)
    Abrisqueta, Pau
    Loscertales, Javier
    Jose Terol, Maria
    Ramirez Payer, Angel
    Ortiz, Macarena
    Perez, Inmaculada
    Cuellar-Garcia, Carolina
    Fernandez de la Mata, Margarita
    Rodriguez, Alicia
    Lario, Ana
    Delgado, Julio
    Godoy, Ana
    Arguinano Perez, Jose Ma
    Berruezo, Ma Jose
    Oliveira, Ana
    Hernandez-Rivas, Jose-Angel
    Dolores Garcia Malo, Maria
    Medina, Angeles
    Garcia Martin, Paloma
    Osorio, Santiago
    Baltasar, Patricia
    Fernandez-Zarzoso, Miguel
    Marco, Fernando
    Vidal Mancenido, Ma Jesus
    Smucler Simonovich, Alicia
    Lopez Rubio, Montserrat
    Jarque, Isidro
    Suarez, Alexia
    Fernandez Alvarez, Ruben
    Lancharro Anchel, Aima
    Rios, Eduardo
    Losada Castillo, Maria del Carmen
    Perez Persona, Ernesto
    Garcia Munoz, Ricardo
    Ramos, Rafael
    Yanez, Lucrecia
    Bello, Jose Luis
    Loriente, Cristina
    Acha, Daniel
    Villanueva, Miguel
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (12): : E985 - E999
  • [29] Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Emond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [30] Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naive Patients With Chronic Lymphocytic Leukemia: A Cross-Trial Comparison
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 2 - 3
12345